DURHAM, N.C. — Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to ATSN-101, the company’s investigational gene therapy being evaluated in...
research News
A cross-sectional study found that caregivers of patients with ovarian cancer were experiencing symptoms of depression and anxiety which were affected by attachment avoidance. These findings were published in Current Oncology. Caregivers are an important component of successful cancer treatment, as they ensure treatment adherence as well as provide much needed...
Los Angeles, Calif. – A team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combination of a short course of powerful and intense hormonal therapy with targeted radiation is safe and effective in treating people with prostate cancer that has come back and has spread to other parts...
ROCKVILLE, Md. & EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. announced today the submission of its Investigational New Drug application (IND) to the U.S. Food and Drug Administration (FDA) for AUR200, a potential next generation therapy for B-cell mediated autoimmune diseases. Upon receiving FDA clearance to proceed with proposed research, Aurinia...
Hamilton, Bermuda – Auris Medical Holding Ltd. (NASDAQ: EARS), a company dedicated to addressing unmet medical needs through RNA therapeutics, allergy and viral infection protection, and inner ear therapeutics, today announced the publication of positive results from an in vivo study demonstrating significant inhibition of tumor growth by siRNA knock-down...
Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease. Their findings will be published today in the prestigious journal Nature Genetics. “For decades the cause of MS has...
Canberra, Australia – Researchers from The Australian National University (ANU) have discovered a previously unknown ability of a group of immune system cells, known as Atypical B cells (ABCs), to fight infectious diseases such as malaria. The discovery provides new insight into how the immune system fights infections and brings...
Canberra, Australia – More than a quarter of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but our bodies also need cholesterol to survive. Now, scientists from The Australian National University (ANU) say its role as a basic building block of life holds...
DENVER, Colorado – Based on results from the CheckMate743 trial, the dual regimen of ipilimumab and nivolumab is the standard of care for the treatment of unresectable pleural mesothelioma. But research published today in the Journal of Thoracic Oncology (JTO) showed that a group of Australian patients treated with that...
Dublin – Neuroscientists at Trinity College in Dublin have discovered a fascinating connection between the retention of early life memories and brain developmental trajectories associated with autism. Most of us remember little of our experiences from before two years of age. This form of memory loss, termed “infantile amnesia” refers...